Jakafi is a preferred treatment for myelofibrosis
Myelofibrosis is a type of bone marrow cancer that leads to the formation of fibrous tissue in the bone marrow and results in scarring, which impairs the normal production of blood cells. The exact cause of myelofibrosis is unknown, but it is believed to be caused by genetic mutations in the blood cells. Jakafi (ruxolitinib) […]